ABSTRACT
Treatment guidelines for the management of pediatric status epilepticus (PSE) are often institution-specific. We aim to characterize deviation from our hospital-based PSE treatment guidelines, the total dosage of benzodiazepines administered, and the need for intubation. The study population included all patients with an ICD -10 code for PSE who required admission to the Pediatric Intensive Care Unit (PICU) from April 2019 to April 2022. There were 66 PICU admissions. All patients with concern for PSE and altered mental status are admitted to the PICU. The cohort was divided between those treated according to the PSE protocol (benzodiazepine dose (0.05â¯mg/kg- 0.2â¯mg/kg) versus those who had low dose (≤0.05â¯mg/kg) and high-dose benzodiazepine (> 0.2â¯mg/kg) totals. The dosage was calculated as the total dose of benzodiazepines received pre-hospital and in the ED before intubation or transport. Forty-one (62â¯%) of patients received high-dose benzodiazepines (median 0.34â¯mg/kg [IQR 0.29-0.56], 19 (29â¯%) received recommended-dose benzodiazepines (median 0.13â¯mg/kg [IQR 0.09,0.15] and 6 (9â¯%) received low-dose (median 0.05â¯mg/kg [IQR 0.03,0.05]. The high-dose group was 15.9 (95â¯% CI = 3.7, 99.9) times more likely to be intubated controlling for the location of care (tertiary versus community hospital), and the age of the patient. The recommended-dose and low-dose groups required intubation with much less frequency.